TIA-1 (T-cell intracellular antigen-1) and TIAR (TIA-1-related protein) are evolutionarily conserved RNA-binding proteins at the center of cellular stress responses. Through their N-terminal RNA recognition motifs and C-terminal prion-like domain (PLD), they regulate mRNA translation, splicing, and stability, and drive the assembly of stress granules (SGs) via liquid-liquid phase separation. During viral infection, TIA-1/TIAR function spans a continuum between antiviral defense and pro-viral subjugation, rather than acting as a simple binary switch. Their canonical antiviral role is to nucleate SGs that stall viral translation and act as platforms for innate immune signaling. Viruses, in turn, disrupt these defenses in a temporal hierarchy: they first target the direct RNA regulatory functions of TIA-1/TIAR and later dismantle the SG platform. Viral RNA structures can act as high-affinity baits, competitively recruiting these proteins away from SGs and toward viral replication centers. Viral proteases can cleave key SG nucleators to dismantle the antiviral platform while sparing TIA-1/TIAR for pro-viral function. Here, we review the molecular mechanisms that underlie this functional spectrum in infections by diverse viruses. We propose and refine a “competitive subcellular compartmentalization” model, wherein the outcome of infection is shaped by a molecular tug-of-war for TIA-1/TIAR between antiviral SGs and pro-viral replication complexes. In physicochemical terms, disparate viral strategies can be unified as perturbations that lower the threshold for phase separation, shifting the equilibrium toward pro-viral condensates. Finally, we discuss the therapeutic potential of targeting this central host–virus interface.
No takes yet. Share an insight, caveat, or question.
Ouyang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: